SWITZERLAND-US-PHARMACEUTICAL-ACQUISITION

US pharmaceuticals giant Johnson & Johnson announced it was buying Europe's biggest bio-pharmaceutical firm, Switzerland's Actelion, for $30 billion. Photo: AFP, Michael Buholzer

March 30, 2017 8:27 PM (UTC+8)